177 related articles for article (PubMed ID: 25613741)
1. Polymorphism of the E-cadherin gene CDH1 is associated with susceptibility to vitiligo.
Tarlé RG; Silva de Castro CC; do Nascimento LM; Mira MT
Exp Dermatol; 2015 Apr; 24(4):300-2. PubMed ID: 25613741
[TBL] [Abstract][Full Text] [Related]
2. CDH1 and DDR1 common variants confer risk to vitiligo and autoimmune comorbidities.
Almasi-Nasrabadi M; Amoli MM; Robati RM; Rajabi F; Ghalamkarpour F; Gauthier Y
Gene; 2019 Jun; 700():17-22. PubMed ID: 30890477
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of the DDR1 gene are associated with vitiligo in two independent Brazilian population samples.
Silva de Castro CC; do Nascimento LM; Walker G; Werneck RI; Nogoceke E; Mira MT
J Invest Dermatol; 2010 Jul; 130(7):1813-8. PubMed ID: 20182441
[TBL] [Abstract][Full Text] [Related]
4. Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin.
Ricard AS; Pain C; Daubos A; Ezzedine K; Lamrissi-Garcia I; Bibeyran A; Guyonnet-Dupérat V; Taieb A; Cario-André M
Exp Dermatol; 2012 Jun; 21(6):411-6. PubMed ID: 22507556
[TBL] [Abstract][Full Text] [Related]
5. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo.
Elgarhy LH; Abdullatif A; Abdelazim R; El-Desouky KI
G Ital Dermatol Venereol; 2016 Oct; 151(5):473-9. PubMed ID: 26091274
[TBL] [Abstract][Full Text] [Related]
6. Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility.
Laddha NC; Dwivedi M; Mansuri MS; Singh M; Patel HH; Agarwal N; Shah AM; Begum R
PLoS One; 2014; 9(9):e107020. PubMed ID: 25221996
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms of discoidin domain receptor tyrosine kinase 1 (DDR1) and non-segmental vitiligo in the Korean population.
Kim HJ; Uhm YK; Yun JY; Im SH; Yim SV; Chung JH; Shin MK; Lee MH
Eur J Dermatol; 2010; 20(2):231-2. PubMed ID: 20007060
[No Abstract] [Full Text] [Related]
8. New insights into immune mechanisms of vitiligo.
Boniface K; Taïeb A; Seneschal J
G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
[TBL] [Abstract][Full Text] [Related]
9. Reduced immunohistochemical expression of CCN3 in vitiligo.
Faria AR; Jung JE; Silva de Catro CC; de Noronha L
Indian J Dermatol Venereol Leprol; 2018; 84(5):558-562. PubMed ID: 29998862
[TBL] [Abstract][Full Text] [Related]
10. Expression of discoidin domain receptor 1 and E-cadherin in epidermis affects melanocyte behavior in rhododendrol-induced leukoderma mouse model.
Abe Y; Hozumi Y; Okamura K; Suzuki T
J Dermatol; 2020 Nov; 47(11):1330-1334. PubMed ID: 32770866
[TBL] [Abstract][Full Text] [Related]
11. Association of e-cadherin gene CDH1 polymorphism -160 C/A with susceptibility to develop vitiligo.
Kubelis-López DE; Zapata-Salazar NA; Salinas-Santander MA; Sánchez-Domínguez CN; Morlett-Chávez JA; Ocampo-Candiani J
An Bras Dermatol; 2023; 98(3):376-378. PubMed ID: 36754648
[No Abstract] [Full Text] [Related]
12. Vitiligo--part 1.
Tarlé RG; Nascimento LM; Mira MT; Castro CC
An Bras Dermatol; 2014; 89(3):461-70. PubMed ID: 24937821
[TBL] [Abstract][Full Text] [Related]
13. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
Fukunaga-Kalabis M; Martinez G; Liu ZJ; Kalabis J; Mrass P; Weninger W; Firth SM; Planque N; Perbal B; Herlyn M
J Cell Biol; 2006 Nov; 175(4):563-9. PubMed ID: 17101694
[TBL] [Abstract][Full Text] [Related]
14. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
Gauthier Y; Cario Andre M; Taïeb A
Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615
[TBL] [Abstract][Full Text] [Related]
15. The genetics of generalized vitiligo and associated autoimmune diseases.
Spritz RA
Pigment Cell Res; 2007 Aug; 20(4):271-8. PubMed ID: 17630960
[TBL] [Abstract][Full Text] [Related]
16. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
Blomhoff A; Kemp EH; Gawkrodger DJ; Weetman AP; Husebye ES; Akselsen HE; Lie BA; Undlien DE
Pigment Cell Res; 2005 Feb; 18(1):55-8. PubMed ID: 15649153
[TBL] [Abstract][Full Text] [Related]
17. The genetics of generalized vitiligo.
Spritz RA
Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
[TBL] [Abstract][Full Text] [Related]
18. miR-9 regulates melanocytes adhesion and migration during vitiligo repigmentation induced by UVB treatment.
Su M; Yi H; He X; Luo L; Jiang S; Shi Y
Exp Cell Res; 2019 Nov; 384(1):111615. PubMed ID: 31499059
[TBL] [Abstract][Full Text] [Related]
19. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
20. Physiopathology and genetics of vitiligo.
Passeron T; Ortonne JP
J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
